In comparison, recent studies showed that human A3B driven tumors in mice (hepatocellular carcinomas and B cell lymphomas) exhibit an opposite APOBEC3 mutation signature bias with 53% YTCW and 47% RTCW [72]. This evidence concerns the gene APOBEC3B and hepatocellular carcinoma.